Rocky Mountain Cancer Centers RMCC is a clinical research site located in Greenwood Village, Colorado, United States.
Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.
Rocky Mountain Cancer Centers RMCC has participated in 6 clinical trials.
Therapeutic areas: Myelodysplastic Syndromes, Diffuse Large B-cell Lymphoma, Metastatic Renal Cell Carcinoma.
Sponsors: Novartis Pharmaceuticals.
Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Rocky Mountain Cancer Centers RMCC has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Rocky Mountain Cancer Centers RMCC has 6 clinical trials on record. Their work covers Myelodysplastic Syndromes, Diffuse Large B-cell Lymphoma, Metastatic Renal Cell Carcinoma.
Rocky Mountain Cancer Centers RMCC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.